, Tracking Stock Market Picks
Enter Symbol:
Genentech, Inc. (DNA) [hlAlert]

up 19.63 %

Genentech, Inc. (DNA) rated Buy with price target $105 by UBS

Posted on: Tuesday,  Jul 22, 2008  10:25 AM ET by UBS

UBS rated Buy Genentech, Inc. (NYSE: DNA) on 07/22/2008. Previously UBS rated Buy Genentech, Inc. (NYSE: DNA) on 09/21/2007., when
the stock price was $79.38. Since then, Genentech, Inc. has gained 19.64% as of 03/26/2009's recent price of $94.97.
If you would have followed the previous UBS's recommendation on DNA, you would have gained 19.63% of your investment in 552 days.

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/22/2008 10:25 AM Buy
93.59 105.00
as of 12/24/2008
1 Week up  15.67 %
1 Month up  0.49 %
3 Months up  12.65 %
1 YTD up  19.79 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2008 10:25 AM Buy
78.13 95.00
2/13/2008 9:25 AM Buy
71.71 93.00
12/6/2007 9:25 AM Buy
67.58 94.00
10/16/2007 9:39 PM Buy
74.95 100.00
9/21/2007 9:25 AM Buy
79.38 101.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy